A week of commercial deals and government negotiations has resulted in a series of amendments to the legislation aimed at making Google and Facebook...
Pharmacy Benefit Managers (PBMs) were established in the 1960s to control drug costs but have since morphed into one of the most highly concentrated...
A Stigler Center webinar explores how businesses lobby and compete for political power and whether mergers and industry concentration affect lobbying.
Firms compete in markets,...
In an interview with ProMarket, antitrust scholar, lawyer, and businesswoman Dina Srinivasan explains why she believes that if users were given the choice to...
A Stigler Center webinar explores instances where competition turns toxic, whether antitrust policy needs reform, and potential paths forward.
Is there such a thing as...
Targeted at Big Tech, Germany’s new antitrust tool for dealing with large digital platforms rebalances the power between the competition watchdog and those firms.
Around...
How the pre-merger notification regime came about and why we should be careful about discouraging useful mergers.
December 2020 was an extraordinary period in US...
A Stigler Center panel explores the challenges of designing an antitrust enforcement regime that could contend with the political power of corporate monopolies.
Should antitrust...
In the Microsoft antitrust case, Bill Gates’ emails were perhaps the government’s most compelling evidence. Now, as regulators pursue antitrust cases against Facebook and Google,...